Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 June;66(2) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 June;66(2):156-61

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 June;66(2):156-61

DOI: 10.23736/S1824-4785.19.03178-9

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

Uptake pattern of [68Ga]Ga-DOTA-NOC in tissues: implications for inflammatory diseases

Luz K. ANZOLA 1, 2, 3 , Chiara LAURI 2, Carlos E. GRANADOS 4, Bruno LAGANÀ 5, Alberto SIGNORE 2, 3

1 Unit of Nuclear Medicine, Clinica Colsanitas, Bogotà, Colombia; 2 Unit of Nuclear Medicine, Department of Medical-Surgical Sciences and of Translational Medicine, Sapienza University, Rome, Italy; 3 Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; 4 Medicina Nuclear, Hospital San Ignacio, Bogotá, Colombia; 5 Unit of Rheumatology, Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy



BACKGROUND: [68Ga]Ga-DOTA-NOC binds to somatostatin receptor (SSTR) subtypes 2 and 5, also expressed on lymphocytes and macrophages, but no information is available about uptake in tissues that might be affected by a chronic inflammatory process. Our aim was to obtain normal reference values for: [68Ga]Ga-DOTA-NOC uptake in tissues prone to chronic inflammation.
METHODS: Retrospective study in 81 patients who performed the scan for a suspicion of neuroendocrine tumor (NET). We analyzed major joints, salivary glands, thyroid, aortic wall from images acquired after injection of 173.9±1 Mbq of: [68Ga]Ga-DOTA-NOC. We calculated the SUVmax and SUVtarget/SUVgluteus ratio or SUVtarget/SUVaorta ratio. Data are reported as mean±2 or ±3 standard deviations (SD).
RESULTS: SUVmax values appeared more reliable than other ratios. In thyroid we found a mean SUVmax of 1.36±0.45, with no values >3SD; in parotid glands 0.98±0.40, with 2 values >3SD; in submandibular glands 0.99±0.37, with 2 values >3SD; in aortic arch 1.71±0.50, with 1 value >3SD; in thoracic aorta 2.03±0.52, with 1 value >3SD; in abdominal aorta 2.19±0.49, with no value >3SD; in shoulders 0.92±0.31 and in hips 0.87±0.34, with 2 and 4 values >3SD, respectively. These 12 values with SUVmax >3SD, belong to 5 patients, 3 of which had signs of xerostomia and/or arthritis. A statistically significant correlation was observed between SUVmax and age in all examined tissues but in the aorta.
CONCLUSIONS: Tissues in which lymphocytic infiltration may occur show that SUVmax is tissue-dependent. Within tissue variability, an SUVmax greater than the mean +3SD is rarely found amongst patients without a symptomatic chronic inflammatory process but, when found, may highlight a chronic inflammatory condition.


KEY WORDS: Receptors, somatostatin; 68Ga-DOTANOC; Inflammation; Autoimmune diseases

top of page